Why Viking Therapeutics Stock Was Victorious This Week
Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was a winning stock this week. Over the course of the past five trading days, its price rose by almost 18%, according to data compiled by S&P Global Market Intelligence. It seems a global health agency is ready to support the kinds of medications the company is working on.
WHO is backing weight-loss drugs?
On Thursday, citing a memo it had reviewed, Reuters reported that no less a body than the United Nations' World Health Organization (WHO) is gearing up to back the use of obesity drugs. The agency will officially support the use of such medications by adults struggling to lose weight, and will make a push to improve access to the drugs for lower- and middle-income patients.
Drugs approved specifically for weight loss are led in the U.S. by Novo Nordisk 's Wegovy and Zepbound from Eli Lilly. Given that they are relatively easier means of shedding pounds than a consistent diet and exercise regime, they have proven to be highly popular among the public in a country with a worsening obesity problem.
With the runaway success of those two treatments, rival pharmaceutical and biotech companies are racing to develop their own weight-loss drugs. Among the leaders in the race is Viking, whose VK2735 has performed extremely well in phase 2 clinical trials. If the drug eventually wins approval and hits pharmacy shelves, it's certain to at least approach the popularity of Zepbound and Wegovy.
A worldwide problem
Needless to say, it'll get an additional boost from the generally well-respected WHO backing obesity treatments. Although weight management is a particularly vexing challenge in the U.S., it is by no means limited to this country; Viking and its peers have a market throughout the world for this kind of drug.
Should you invest $1,000 in Viking Therapeutics right now?
Before you buy stock in Viking Therapeutics, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $611,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $684,068!*
Now, it's worth noting Stock Advisor 's total average return is889% — a market-crushing outperformance compared to162%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of April 28, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
30 minutes ago
- Globe and Mail
Why Broadcom Stock Slumped Today
Broadcom (NASDAQ: AVGO), the semiconductor company that's profited so much from the artificial intelligence (AI) revolution of late, saw its stock slump 3% through 10 a.m. ET this morning after reporting that it beat earnings last night... just barely. Heading into the company's fiscal second quarter of 2025, which ended May 4, analysts forecast Broadcom would earn $1.57 per share in adjusted profits on sales of just under $15 billion. In fact, Broadcom earned $1.58 per share, and its sales were $15 billion. Broadcom Q1 earnings Sales grew 20% year over year in Q2, setting a new quarterly record boosted by 46% year-over-year growth in revenue from AI chips. Adjusted earnings grew twice as fast, up 43%, but generally accepted accounting principles (GAAP) earnings did even better, more than doubling to $1.03 per share. (So while GAAP profits weren't nearly as good as non-GAAP, at least they're growing faster.) On the other hand, Broadcom noted that its free cash flow (FCF) in Q2 was only $6.4 billion. And while that represented 44% year-over-year growth, in line with adjusted earnings growth, it was apparently less than the $7 billion FCF that analysts had hoped Broadcom would produce. This realization seems to be outweighing the news of the earnings beat, and depressing Broadcom stock today. Is Broadcom stock a buy? Should investors be worried about this? Not necessarily. While I'm not usually thrilled to see such a large gap between GAAP earnings and non-GAAP earnings, Broadcom's generating tremendous free cash flow -- $22.7 billion over the last 12 months, or nearly twice reported net income. The stock's valuation is high; its price-to-free-cash-flow ratio is 52.5. But Broadcom is growing FCF fast enough that I think the valuation might be justified -- and Broadcom stock could still be a buy. Should you invest $1,000 in Broadcom right now? Before you buy stock in Broadcom, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Broadcom wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
Globe and Mail
30 minutes ago
- Globe and Mail
Why Concrete Pumping Stock Is Down Big Today
Economic headwinds and bad weather conspired to cut construction activity, which in turn ate into results at Concrete Pumping Holdings (NASDAQ: BBCP). Shares of the multinational concrete provider traded down 17% as of 11 a.m. ET after the company reported results that fell short of Wall Street expectations. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Headwinds weigh on results Concrete Pumping plays a key part in the construction supply chain, providing concrete and concrete waste management services at job sites in the U.S. and in the United Kingdom. But there is only so much the company can do when demand for concrete slows, a scenario that played out in the most recent quarter. The company lost $0.01 per share on revenue of $93.96 million in its fiscal second quarter ending April 30, compared to Wall Street's forecast for a $0.04 per-share profit on sales of $99 million. Concrete Pumping did a good job keeping costs in line and gross margin is actually up slightly for the first six months of fiscal 2025 compared to a year ago, but the macro story was too much to overcome. "In the second quarter, we continued to navigate a challenging construction environment, marked by persistent macroeconomic headwinds and regional weather disruptions," CEO Bruce Young said in a statement. Management is not anticipating an immediate bounce back. Concrete Pumping cut its full-year revenue forecast to $380 million to $390 million, from $425 million to $445 million, saying it is not forecasting a "meaningful" recovery in the construction market until its fiscal 2026. Is Concrete Pumping stock a buy? Even with the declines, Concrete Pumping is still a long-term winner, up 62% over the past five years. The company has a lot of debt, $387 million at quarter's end, compared to a market capitalization of $317 million, but management remains confident enough in cash flows to pursue opportunistic acquisitions and boost its share buyback program by $15 million. For investors who are bullish long-term on the need for infrastructure revitalization in the U.S. and Western Europe and who are willing to ride out a near-term storm, this decline in Concrete Pumping shares could be viewed as a buying opportunity. Should you invest $1,000 in Concrete Pumping right now? Before you buy stock in Concrete Pumping, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Concrete Pumping wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
Energy and tech stocks help lift S&P/TSX composite, U.S. stocks also higher
TORONTO – Canada's main stock index was up in late-morning trading, helped by strength in energy and technology sectors, while U.S. stock markets also climbed higher. The S&P/TSX composite index was up 81.84 points at 26,424.13. In New York, the Dow Jones industrial average was up 353.70 points at 42,673.44. The S&P 500 index was up 53.32 points at 5,992.62, while the Nasdaq composite was up 198.88 points at 19,497.33. The Canadian dollar traded for 73.04 cents US compared with 73.21 cents US on Thursday. The July crude oil contract was up US$1.10 at US$64.47 per barrel and the July natural gas contract was up two cents US at US$3.70 per mmBTU. The August gold contract was down US$23.10 at US$3,352.00 an ounce and the July copper contract was down five cents US at US$4.88 a pound. Monday Mornings The latest local business news and a lookahead to the coming week. This report by The Canadian Press was first published June 6, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD
